share_log

Morgan Stanley Initiates Coverage On Mural Oncology With Overweight Rating, Announces Price Target of $13

Moomoo 24/7 ·  Apr 4 06:39

Morgan Stanley analyst Judah Frommer initiates coverage on Mural Oncology (NASDAQ:MURA) with a Overweight rating and announces Price Target of $13.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment